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A Series of Ubiquitin Binding Factors
Connects CDC48/p97 to Substrate
Multiubiquitylation and Proteasomal Targeting
similar thioester-linked intermediate with ubiquitin. E3
(ubiquitin ligase) finally bindsboth theE2anda substrate
and catalyzes the transfer of ubiquitin to the substrate.
Ubiquitin itself is often a substrate for further ubiquityla-
tion, andproteinsmodifiedby suchmultiubiquitin chains
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Research of the past decade has revealed a surprisingGermany
complexity of the ubiquitin/proteasome system.Particu-
larly striking is the multiplicity of E2 and E3 enzymes,
which is crucial for the required substrate specificity ofSummary
the proteolytic system (Pickart, 2001). Unexpectedly,
various screens identified additional proteolytic factorsProteindegradation ineukaryotesusually requiresmulti-
that are neither typical E2 or E3 enzymes nor compo-ubiquitylation and subsequent delivery of the tagged
nents or regulators of the proteasome. A significant ad-substrates to the proteasome. Recent studies suggest
vance was a screen by Varshavsky and coworkers forthe involvement of the AAA ATPase CDC48, its cofac-
mutants that stabilize a short-lived artificial ubiquitin-tors, and other ubiquitin binding factors in protein deg-
protein fusion (Ghislain et al., 1996; Johnson et al., 1995).radation, but how these proteins work together is un-
Among these so-called UFD proteins (“ubiquitin-fusionclear. Here we show that these factors cooperate
degradation”) identified in connection with this screensequentially through protein-protein interactions and
are UFD1, UFD2, and CDC48 (p97 in vertebrates).thereby escort ubiquitin-protein conjugates to the pro-
CDC48, a member of the large family of AAA-type
teasome. Central to this pathway is the chaperone
ATPases, forms a homohexameric ring and possesses
CDC48/p97, which coordinates substrate recruitment,
chaperone-like activity (Cao et al., 2003; DeLaBarre and
E4-catalyzed multiubiquitin chain assembly, and pro-
Brunger, 2003; Huyton et al., 2003; Rape et al., 2001;
teasomal targeting. Concomitantly, CDC48 prevents
Rouiller et al., 2002; Ye et al., 2001). UFD1 was later
the formation of excessive multiubiquitin chain sizes shown todimerizewithNPL4 to forma substrate-recruit-
that are surplus to requirements for degradation. In ing cofactor for CDC48 (Hitchcock et al., 2001; Meyer
yeast, this escort pathway guides a transcription fac- et al., 2000; Rape et al., 2001). We isolated UFD2 in a
tor from its activation in thecytosol to its final degrada- biochemical screen and showed that it binds ubiquitin
tion and also mediates proteolysis at the endoplasmic conjugates and CDC48 (Koegl et al., 1999). Notably,
reticulum by the ERAD pathway. UFD2 binds oligoubiquitylated substrates (proteins modi-
fied by one or two ubiquitin moieties only) and is able
Introduction to catalyze an extension of the multiubiquitin chain in
collaboration with E1, E2, and E3. We coined enzymes
Proteolysis is pivotal for cellular and developmental reg- possessing this specific activity, “E4 enzymes,” andpro-
ulation. Due to its irreversible nature, proteolysis is ide- posed that they may be important for regulating degra-
dation of proteins already primed for degradation byally suited for regulating unidirectional pathways suchas
oligoubiquitylation (Koegl et al., 1999). Several addi-cell cycle progression or differentiation. In eukaryotes,
tional ubiquitin-conjugate binding proteins have beenselectiveproteolysis is largelymediatedby theubiquitin/
discovered in recent years. Whereas some of these pro-proteasome system (Pickart, 2001). Early studies have
teins do not seem to be involved in proteasomal degra-indicated that this pathway is divided into two steps:
dation (e.g., they function in protein sorting), severalsubstrate recognition, which is brought about by the
findings indicate that yeast RAD23 and DSK2 and possi-ubiquitin conjugation system, and degradation, cata-
bly also RPN10 function as receptors for ubiquitin conju-lyzed by the 26S proteasome. During the recognition
gates that ferry substrates to the proteasome (Chen andstep, the substrates are concomitantly earmarked for
Madura, 2002; Elsasser et al., 2004; Verma et al., 2004;proteolysis by covalent modification with ubiquitin,
Wilkinson et al., 2001).which is conjugated via its C terminus usually to -amino
CDC48 has received much attention for its mediatedgroups of lysine residues. Conjugation typically requires
functions. Combined with the adaptor SHP1/p47, it isthree classes of enzymes. E1 (ubiquitin-activating en-
involved in membrane fusion (Kondo et al., 1997; Lat-zyme) hydrolysesATPand forms a thioester-linked com-
terich et al., 1995). However, if combinedwith the hetero-plex between itself and ubiquitin. E2 (ubiquitin-conjugat-
dimeric cofactor UFD1/NPL4 (CDC48UFD1/NPL4), CDC48ing enzyme) receives ubiquitin from E1 and forms a
mediates ubiquitin-dependent ER-associated degrada-
tion (ERAD) (Bays et al., 2001; Braun et al., 2002; Jarosch
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plane of the ER for proteasomal degradation. Similarly, of oligoubiquitylated substrates (Koegl et al., 1999),
these data suggest that the enzyme can be seen as aCDC48UFD1/NPL4 mobilizes ubiquitylated SPT23 from the
ER membrane for its nuclear function. specialized E3-like enzyme that recognizes a ubiquitin
moiety of a ubiquitin-protein conjugate as a substrateHere we describe a pathway in which proteolytic sub-
strates are guided to the proteasome by a succession for further ubiquitylation.
of interacting factors. Our data indicate that oligoubiqui-
tylated substrates are first collected by the CDC48UFD1/NPL4 CDC48UFD1/NPL4 Stimulates Substrate
complex, subsequently multiubiquitylated by the E4 Binding by UFD2
enzyme UFD2, and finally bound by RAD23/DSK2 for Next we asked how UFD2 receives oligoubiquitylated
proteasomal targeting. Intriguingly, the multiubiquitin substrates formultiubiquitylation. A clue to this question
chains catalyzed by E4 at the CDC48UFD1/NPL4 complex came from our previous studies showing that UFD2
are restricted in size but sufficiently long enough for binds CDC48 (Koegl et al., 1999). Because CDC48 uses
RAD23/DSK2 binding. All factors of this pathway bind UFD1 and NPL4 as cofactors, we investigated their rela-
ubiquitin conjugates and make contacts with their re- tionship to UFD2. Notably, binding of UFD2 to CDC48
spective upstream or downstream acting factors. We in vivo was reduced both in ufd1-2 and npl4-1 tempera-
show that this escort pathway controls activation and ture-sensitive mutants (Figure 2A), suggesting that
degradation of the NFB-related yeast transcription fac- UFD2-CDC48 interaction is stimulated by the UFD1/
tor SPT23 and that it is involved in ER-associated degra- NPL4 cofactors. CDC48 can interact with ubiquitylated
dation (ERAD). substrates directly (Rape et al., 2001), but association
of ubiquitin conjugates with CDC48 in vivo is reduced
in both ufd1-2 and npl4-1 mutant cells (Figure 2B and
Results see Supplemental Figure S2 on the Cell website). These
results suggest that ubiquitylated substrates are primar-
E4 Multiubiquitylation Activity ily recruited to the CDC48 complex via the cofactors
To investigate the functional relationship between novel UFD1/NPL4 in vivo.
proteolytic factors, we took advantage of artificial ubi- Based on this finding, we then asked whether the
quitin-fusion proteins as model substrates (UFD path- associationofUFD2with ubiquitylated substrates is also
way). These proteins are already primed for degradation stimulated by the substrate-recruiting cofactors of
due to the presence of their ubiquitin domains (Johnson CDC48. We first addressed this question in vivo by
et al., 1995). Ubiquitylation of these substrates proceeds expressing epitope-tagged UFD2 (VSVUFD2) in cells co-
via a two-step reaction (Koegl et al., 1999). The substrate expressing the UFD substrate Ubi-Progal. Whereas im-
is first modified at the ubiquitin portion of the fusion by munoprecipitation with -galactosidase-specific anti-
usually only one or two ubiquitin moieties. This requires bodies revealed strong binding of the substrate to UFD2
E1 (UBA1), E2 (UBC4), and E3 (UFD4) enzymes. In a in wild-type (wt) cells, binding was greatly reduced in
second step, E4 (UFD2) binds the oligoubiquitylated cells defective in either UFD1 or NPL4 (Figure 2C). To
substrate and catalyzes together with E1, E2, and E3 confirm this finding in vitro, we used recombinant
the addition of further ubiquitin moieties leading to a CDC48, UFD1, and NPL4, which, if mixed, form a stable
long multiubiquitin chain. Concomitant with chain elon- CDC48UFD1/NPL4 complex as judged by gel filtration (Figure
gation, the ubiquitin-ubiquitin linkage within the multi- 2D). To monitor binding, we used ubiquitin-GST (Ubi-
ubiquitin chain is apparently switched from a lysine-29 GST) as a substrate and added MBP-tagged UFD2
(K29)- to a lysine-48 (K48)-linked multiubiquitin chain (MBPUFD2). By pulling down GST with glutathione beads,
(Koegl et al., 1999; Saeki et al., 2004). we found that UFD2 bound Ubi-GST weakly (Figure 2E),
The yeast E4 enzyme UFD2 is the founding member but when CDC48UFD1/NPL4 was added to the sample, bind-
of so-called U-box proteins (Koegl et al., 1999). Because ing of UFD2 to Ubi-GST was strongly stimulated.
the U-box is structurally similar to the RING fingers of CDC48 is known to localize both to the cytosol and
certain E3 ubiquitin ligases (Aravind and Koonin, 2000; the nucleus, and it may shuttle between these compart-
Ohi et al., 2003), we asked for the role of this domain in ments (Madeo et al., 1998). Interestingly, UFD2 is pre-
UFD2. The assay we used is a fully defined in vitro dominantly concentrated in the nucleus but is signifi-
ubiquitylation system using E1, E2, and E3 enzymes and cantly relocated to the cytoplasm in cdc48-6 or ufd1-2
the fusion protein ubiquitin-protein A (Ubi-ProtA) as a mutant cells (see Supplemental Figure S3). This result
substrate (Koegl et al., 1999). When we deleted the suggests that nuclear localization of UFD2 is mediated
C-terminal U-box (UFD2U-box), the protein was devoid in part by the CDC48UFD1/NPL4 machinery.
of E4 activity (Figure 1A). The U-box was also required
in vivo, as indicated by the complete stabilization of the CDC48UFD1/NPL4 Restricts
otherwise short-lived UFD substrate ubiquitin-proline- Multiubiquitin Chain Assembly
-galactosidase (Ubi-Progal; Johnson et al., 1995) in The finding that the E4 enzyme collects its substrates
a ufd2U-box mutant strain (Figure 1B). Furthermore, simi- via the CDC48UFD1/NPL4 complex prompted us to study
lar to RING fingers (Weissman, 2000), the U-box could multiubiquitylation in vitro in the presence of the chaper-
catalyze “autoubiquitylation” (i.e., ubiquitylation of the one-like complex. By using three different model sub-
U-box protein by E1 and E2) (see Supplemental Figure strates (Ubi-ProtA,Ubi-GST, andUbi-Progal), we found
S1 at http://www.cell.com/cgi/content/full/120/1/73/ that the size of E4-catalyzed multiubiquitin chains was
reduced by the activity of the CDC48 complex (FiguresDC1/). Because UFD2 recognizes the ubiquitin moieties
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Figure 1. The U-Box Is Essential for E4 Activ-
ity of UFD2
(A) The U-box is required but not sufficient for
E4 activity of UFD2 in vitro. UFD2, UFD2U-box,
and GST-U-box were added to an in vitro
ubiquitylation reaction of the substrate Ubi-
ProtA containing E1, E2, and E3. Only wt but
not UFD2U-box or GST-U-Box possesses E4
activity. Proteins were detected by anti-pro-
tein A immunoblotting.
(B) The U-box is essential for degradation of
Ubi-Progal in vivo. Degradation of Ubi-Progal
was studied by pulse-chase experiments in
wt, ufd2, and cells expressing UFD2U-box
(ufd2U-box) followed by autoradiography. The
asterisk marks a characteristic degradation
product of Ubi-Progal.
3A–3C). This effect was dose dependent and mediated assays using purified proteins showed that both RAD23
by theCDC48 protein but apparently not by its cofactors and DSK2 but not RPN10 binds UFD2 directly and effi-
(Figure 3D). It was specific for CDC48, as even a large ciently (Figure 4A). However, in contrast to UFD1/NPL4
excess of BSA did not cause a similar reduction (Figure and UFD2, the receptor proteins RAD23 and DSK2 (and
3A). CDC48 selectively inhibited the formation of very RPN10) are apparently not cofactors of CDC48, as no
long E4-catalyzed chains, thereby restricting the major- direct interaction could be detected (Figure 4B). How-
ity of multiubiquitin chains to an average of three to six ever, we found that UFD2 can bind CDC48 and RAD23
ubiquitinmoieties (termed “size-restricted chains” in the simultaneously, forming a ternary complex (Figure 4C).
following). Importantly, CDC48 did not completely pre- Because the association of CDC48 with RAD23 was
vent E4 activity, as the size-restricted chains contained apparently bridged by UFD2, CDC48 associated with
in general at least one to three more ubiquitin moieties RAD23 in vivo and in cell extracts significantly weaker
than chains assembled in the absence of E4 (Figures than with its cofactors UFD1/NPL4 and UFD2 (Figures
1A and 3A–3C and Koegl et al. [1999]). Moreover, the 4D and 4E). Mapping assays showed that RAD23 binds
inhibitory effect could not be reverted by subsequent to an N-terminal region of UFD2, whereas CDC48 binds
addition of a surplus of E4 to the reaction (Figure 3E), to a different domain of UFD2, which is proximal to the
indicating that size restriction is not caused by E4 titra- C-terminal U-box (Figure 4F). Interestingly, UFD2 binds
tion or a simple inactivation mechanism. to a C-terminal region of CDC48 (Figure 4G), which dis-
tinguishes this protein form the substrate-recruiting fac-
tors UFD1/NPL4 and SHP1, which bind to CDC48’sRAD23 and DSK2 Act Downstream
N-terminal domain (Ye et al., 2003).of UFD2-CDC48
Motivated by the finding that UFD2 interacts with bothA cursory interpretation of the above findings is that the
RAD23 and DSK2, and given their known role in the UFDCDC48 complex counteracts E4 activity. However, the
pathway (Lambertson et al., 1999;RaoandSastry, 2002),genetic data demonstrate that the CDC48 complex is
we tested whether RAD23 and DSK2 can bind the ubi-required for UFD degradation (Ghislain et al., 1996;
quitylated substrates generated in our in vitro system.Hoppe et al., 2000; Johnson et al., 1995; Rape et al.,
In fact, GST-tagged variants of RAD23 and DSK2 were2001), and hence the complex plays a positive and not
able to bind UFD substrates modified by three or morea negative role in the proteolytic pathway.
ubiquitin moieties, whereas mono- or diubiquitiylatedTo address this issue, we asked for possible down-
substrates were not detectably recognized (Figure 5A).stream acting factors. Ubiquitylated substrates can be
This finding is in line with a recent study, which showedtargeted to proteasomes via RAD23 and RPN10 (Chen
that the maximum affinity of human RAD23 for multiubi-and Madura, 2002; Elsasser et al., 2004; Verma et al.,
quitin chains is reached with a chain length of four to2004; Wilkinson et al., 2001). Whereas a fraction of
six ubiquitin moieties (Raasi et al., 2004). Thus, RAD23RPN10 is a stable constituent of the proteasome and
and DSK2 possess precisely the binding propertybinds ubiquitin conjugates via its UIM motif (Fu et al.,
needed for collecting size-restricted multiubiquitin1999; van Nocker et al., 1996; Verma et al., 2004), RAD23
chains. In contrast, RPN10 interacted with size-restrictedis soluble and interacts with conjugates through its UBA
chains only very weakly, as it preferred longer chainsdomains (Wilkinson et al., 2001). RAD23 possesses an
for binding. Intriguingly, binding of RAD23 to UFD2N-terminal ubiquitin-like domain, which mediates inter-
in vivo was reduced in npl4-1 mutants (Figure 5B), andactionwith theproteasome (Schauber et al., 1998). Nota-
binding of ubiquitylated -galactosidase to RAD23 wasbly, RAD23 also bindsUFD2via its ubiquitin-like domain,
diminished in mutants defective in UFD1, NPL4, CDC48,and binding of RAD23 to the proteasome and to UFD2
and UFD2 (Figure 5C). These findings strongly suggestare competing reactions (Kim et al., 2004). In yeast,
that the respective proteins cooperate in a commonRAD23 and DSK2 have similar domain structures and
overlapping functions (Biggins et al., 1996). Pull-down pathway and deliver ubiquitylated substrates from the
Cell
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CDC48UFD1/NPL4 chaperone via the UFD2 E4 enzyme to
the proteasome-targeting factor RAD23.
Turnover of the SPT23 Transcription Factor
One of the essential functions of the CDC48UFD1/NPL4 com-
plex in yeast is its role in the OLE pathway that regulates
the synthesis of unsaturated fatty acids (Hoppe et al.,
2000; Rape et al., 2001). SPT23, the key regulator of this
pathway, is an ER bound transcription factor that is
activated by proteolytic processing involving the ubiqui-
tin ligase RSP5 and proteasomes. The processed,
monoubiquitylated molecule is then segregated from its
uncleavedSPT23partner by the activity of CDC48UFD1/NPL4
and subsequently ferried into the nucleus (Rape et al.,
2001). The key target of SPT23 is OLE1, the gene for
the ER bound enzyme 9 fatty acid desaturase (Zhang
et al., 1999). This enzyme generates unsaturated fatty
acids (e.g., oleic acid), and its misregulation by either
over- or underexpression is toxic for cells (Hoppe et al.,
2000; Stukey et al., 1989).
We noticed thatufd2mutants are strongly hypersen-
sitive to oleic acid (Figure 6A). Similar phenotypes were
observed with the rad23 dsk2 double mutant and,
somehow weaker, with the rpn10 mutant. These find-
ings suggest that the OLE pathway is hyperactive in
these mutants and that any further addition of oleic acid
to cells causes slow growth. Importantly, ufd2 and
rad23mutants exhibit an epistatic relationship (i.e., the
ufd2 rad23 double mutant has a similar phenotype
as the ufd2 single mutant), indicating that UFD2 and
RAD23 function in the same pathway. In contrast, UFD2
and RPN10 seem to function in parallel pathways, as
the double mutant is much more sensitive than either
single mutants (Figure 6A).
SPT23 processing occurs normally in all these mu-
tants (Figure 6B), demonstrating that the respective fac-
myc antibodies, and bound VSVCDC48 was detected by anti-VSV
immunoblots. The amount of coprecipitated VSVCDC48 is reduced
in ufd1-2 and npl4-1mutant cells compared to wt. Cells were shifted
to the restrictive temperature of ufd1-2 and npl4-1 (37C) for 2 hr,
and growth was supported by oleic acid in the medium (Rape et
al., 2001). Control indicates wt cells not expressing tagged UFD2.
(B) The interaction of CDC48 with ubiquitylated proteins is reduced
in ufd1-2 and npl4-1 mutant cells grown at 37C. Ubiquitin conju-
gates were immunoprecipitated from wt, npl4-1, and ufd1-2 cells
overexpressing myc-tagged ubiquitin. Coprecipitated CDC48 was
detected by anti-CDC48 immunoblots in wt but hardly in ufd1-2 and
npl4-1 cells. Control indicates wt cells overexpressing nontagged
ubiquitin.
(C) UFD2 binds Ubi-Progal with lower affinity in ufd1-2 and npl4-1
mutant cells. Ubi-Progal was immunoprecipitated from cells ly-
sates of wt, ufd1-2, and npl4-1 grown at 37C. Coprecipitated
VSVUFD2 was detected by anti-VSV immunoblots. Control indicates
wt cells not expressing Ubi-Progal.
(D) Recombinant CDC48, UFD1, and NPL4 were incubated for 1 hr
at 4C and loaded on a Superose 6 column. The complex, eluted in
one peak, was pooled, and an aliquot was run on an SDS PAGE
and stained with Coomassie brilliant blue.
(E) CDC48UFD1/NPL4 increases the affinity of MBPUFD2 toward Ubi-GST
in vitro. GST or Ubi-GST (0.5 M) (bottom panel) bound to glutathi-
Figure 2. Ubiquitin-Conjugate Binding of UFD2 Is Stimulated by one beads was incubated with either CDC48UFD1/NPL4 (about 0.5 M
CDC48UFD1/NPL4 of the complex) or UFD2 (0.25 M) or in combination. After washing,
the retained proteins on glutathione beads were detected by Coo-(A) Interaction of UFD2 with CDC48 is stabilized by UFD1 and NPL4.
Chromosomallymyc-taggedUFD2was immunoprecipitatedby anti- massie blue staining.
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Figure 3. CDC48UFD1/NPL4 Restricts Multiubiquitin Chain Assembly
(A) CDC48UFD1/NPL4 restricts E4-catalyzed multiubiquitylation of the substrate Ubi-ProtA. (Left panel) Ubiquitylation was performed in vitro by
E1, E2, and E3 (lane 1) or by the same enzymes plus E4 (0.25 M) (lane 2). Increasing amounts of the CDC48UFD1/NPL4 complex were added to
the reaction in a 1:1, 2:1, 4:1, and 8:1 molar ratio of the complex to the substrate (0.125 M) (lanes 3–6) (in the complex, the CDC48:UFD1:NPL4
subunit ratio was put as 6:3:3). (Right panel) A similar experiment was performed by comparing reactions done in the presence of either the
CDC48 complex (lane 2, 8:1 to the substrate, as above) or with BSA (8:1, 40:1, 80:1 to the substrate). The reaction products were analyzed
by anti-ProtA immunoblots.
(B and C) Similar to (A), except that Ubi-GST or Ubi-Progal were used as substrates. The CDC48 complex was present in excess over the
substrate. The reactions were analyzed by anti-GST or anti-galactosidase immunoblots.
(D) Size restriction is mediated by CDC48. Ubiquitylation was performed as in (A). Hexameric CDC48 (1 M), trimeric UFD1/NPL4 heterodimer
(1 M), or both were added to the reaction, reflecting an 8-fold molar ratio to the substrate (0.125 M). The reaction products were analyzed
by anti-ProtA immunoblots.
(E) Excess of UFD2 does not prevent ubiquitin chain size restriction. Ubiquitylation was performed as in (A) in presence of increasing amounts
of the CDC48 complex to an 8-fold molar ratio to the substrate (0.125 M) and constant amounts of UFD2 (0.25 M) (lanes 1–5). Subsequently,
the concentration of UFD2was stepwise increased to approximately 3M (lanes 6–9). The reaction products were analyzed by anti-ProtA immu-
noblots.
tors do not mediate SPT23 activation. However, we ob- in the rad23 single mutant but strongly in the rad23
dsk2 double mutant, emphasizing their overlappingserved that p90, the processed,monoubiquitylated form
of SPT23, which is short-lived in wt cells (Hoppe et al., activities. Notably, the strength of p90 stabilization in
the mutants correlates well with their oleic acid hyper-2000), was partially stabilized in the ufd2 mutant. This
indicates that E4 activity is important for p90 break- sensitivities (Figure 6A). Moreover, the comparatively
mild phenotypes of rpn10mutants also draw a paralleldown, and, indeed, UFD2 binds p90 in vivo (Supplemen-
tal Figure S1C). The rpn10 single mutant stabilized to the limited ability of RPN10 to bind size-restricted
multiubiquitin chains (Figure 5A). By using alleles thatp90 only weakly, but the ufd2 rpn10 double mutant
stabilized p90 very strongly (Figure 6B). This behavior still allow significant SPT23 processing at the restrictive
temperature, we also found that the turnover of p90suggests that UFD2 and RPN10 functionmainly in paral-
lel p90 degradation pathways and that both pathways strictly depends on the ubiquitin ligase RSP5 (rsp5-1)
and the proteasome (cim3-1) (Figure 6B, bottom panel).must be blocked in order to get a nearly complete stabili-
zation. Similarly, SPT23 p90 was only weakly stabilized In conclusion, these data suggest a model in which
Cell
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Figure 4. RAD23 and DSK2 Act Downstream of UFD2
(A) UFD2 binds to RAD23 and DSK2. Equimolar amounts of either GST or GST fusions of RPN10, RAD23, and DSK2 were bound to glutathione
beads and incubated for 1 hr at 4C with recombinant UFD2. Bound proteins were analyzed by Coomassie staining after SDS PAGE. The
input shows 15% of the UFD2 protein used for the pull-down experiments.
(B) RAD23 and DSK2 are not cofactors of CDC48. Pull-down experiments similar to (A) with GST; GST-UFD1 complexed with NPL4; and GST
fusions of RPN10, DSK2, RAD23, and UFD2 incubated with recombinant CDC48. Proteins isolated were analyzed by SDS PAGE and Coomassie
staining. The input shows 15% of the protein used in the pull-down experiments.
(C) CDC48, UFD2, and RAD23 form a ternary complex. Pull-down experiments with GST or GST-RAD23 in the absence or presence of CDC48
and UFD2 as indicated. Isolated proteins were analyzed by Coomassie staining (upper panel) and by an anti-CDC48 immunoblot (lower panel).
The input shows 40% of UFD2 and 7% of CDC48 used in the pull-down experiments.
(D) RAD23 is weakly associated with CDC48 in vivo. Cleared extracts of wt cells were subjected to immunoprecipitation by CDC48-specific
antibodies or IgG as control. The precipitated material was immunoblotted and probed with anti-CDC48 antibodies or RAD23 antiserum.
(E) RAD23 is weakly associated with CDC48 in cell extracts. Equimolar amounts of GST or GST fusions of RAD23, UFD2, or UFD1 (complexed
with NPL4) were bound to glutathione beads. Cleared wt cell extract was added to the loaded beads and incubated for 1 hr at 4C. Bound
material was analyzed by anti-CDC48 immunoblots. The input shows 2% of the extract used for the pull-down assays.
(F) CDC48 and RAD23 interaction domains in UFD2. Two-hybrid interaction of full-length or C-terminal deletion constructs of UFD2 with
CDC48 and RAD23. Empty vectors are indicated by “–.” The UFD2 constructs used are schematically shown on the right.
(G) UFD2 interaction domains in CDC48. Pull-down experiments of equimolar amounts of GST, GST-CDC48, GST-CDC481–208aa, and GST-
CDC48208–835aa in presence of UFD2. The isolated proteins were analyzed by anti-UFD2 immunoblots. The input shows 10% of the protein used
in the pull-down experiment. The CDC48 constructs used are schematically shown on the right. D1 and D2 refer to the two AAA domains
of CDC48.
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Figure 5. Ubiquitin-Conjugate Binding of
RAD23
(A) Multiubiquitin chain binding properties.
(Left panel) Multiubiquitylation was per-
formedeither in the presence (left) or absence
(right) of an excess of CDC48UFD1/NPL4 over the
substrate as described in Figure 3. Proteins
modified by multiubiquitin chains were sub-
jected to GST pull-downs using equimolar
amounts of either GST or GST fusions of
RPN10, DSK2, and RAD23 bound to glutathi-
one beads and analyzed by anti-ProtA immu-
noblots. For the GST-RPN10 lanes, 1.8 times
more sample was applied to the gel than for
GST-DSK2 and GST-RAD23 to visualize
bound material. The input lane shows 40%
of the multiubiquitylated substrates used for
the pull-downs. (Right panel) In vitro-trans-
lated, radiolabeled cyclin B N-terminal frag-
ment (NT) was ubiquitylated by E1, UbcX, and
immunopurified APC/C. The ubiquitylated
substrate was incubated with equimolar
amounts of GST or GST-RAD23 bound to glu-
tathione beads and analyzed by autoradio-
graphy. The input shows 50% of the material
used for the pull-down.
(B) Interaction of RAD23 and UFD2 in vivo is
influenced by the substrate-recruiting factor
NPL4. Cleared extracts of wt, ufd2, ufd1-2,
and npl4-1 cells were subjected to immuno-
precipitations with anti-UFD2 antibodies and
the precipitated material analyzed by im-
munoblots with anti-UFD2 antibodies and
RAD23 antiserum.
(C) RAD23 bindsUbi-Progal with lower affin-
ity in ufd1-2, npl4-1, cdc48-6, and ufd2
mutant cells. Ubi-Progal was immunopre-
cipitated from cleared lysates with -galac-
tosidase-specific antibodies. Coprecipitated
RAD23 was detected by anti-RAD23 immu-
noblots. Control indicates wt cells not ex-
pressing Ubi-Progal. Temperature-sensitive
mutants were shifted to 37C for 3 hr in me-
dium supplemented with oleic acid.
SPT23 p90 breakdown is mediated by two alternative found that the short-lived ER membrane protein OLE1
(Braun et al., 2002), the short-lived HMG-CoA reductasepathways. One pathway depends on UFD2-catalyzed
HMG2 (Bays et al., 2001), and the artificial ERAD modelp90multiubiquitylation (in collaboration with E1, E2, and
substrate Deg1SEC62 (Mayer et al., 1998)weremoderatelythe E3 ligase RSP5), followed by RAD23/DSK2 binding
but significantly stabilized in ufd2 mutants (Figure 6Cand subsequent proteasomal degradation. The alterna-
and data not shown). In contrast, only weak (OLE1,tive route seems to depend on RSP5 as well, yet without
Deg1SEC62) or no (HMG2) stabilization of ERAD sub-a requirement for UFD2, and it involves RPN10.
strateswas detected inrpn10mutants. However, when
we combined both deficiencies in a ufd2 rpn10 dou-
ERAD ble mutant, we observed strong stabilization of OLE1
Another important activity of the CDC48UFD1/NPL4 complex and Deg1SEC62 (Figure 6C and data not shown). Hence,
is its role in ERAD. It is believed that ERADsubstrates are also in ERAD, the proteins UFD2 and RPN10 seem to
expelled from the ER via an ER channel, ubiquitylated at function in parallel pathways. As recently reported (Med-
the cytosolic face of the membrane, and subsequently icherla et al., 2004) for the short-lived ERAD substrate
mobilized from themembrane and forwarded to the pro- CPY* (amutant formof the soluble protein carboxypepti-
teasome by the CDC48UFD1/NPL4 complex (Bays et al., dase-Y), OLE1, HMG2, and Deg1SEC62 were also strongly
2001; Braun et al., 2002; Jarosch et al., 2002; Rabinovich stabilized in the rad23 dsk2 double mutant but only
et al., 2002; Ye et al., 2001, 2003). moderately in the respective single mutants. Notably,
To investigate whether the proteins that act down- Deg1SEC62was onlymarginally more stabilized in a ufd2
stream of CDC48 in the UFD and OLE pathways are also rad23 double mutant than in a ufd2 single mutant,
involved in ERAD, we followed the turnover of typical substantiating the finding that UFD2 and RAD23 func-
tion in the same pathway. Together, these data demon-ERAD substrates in the respective mutants. Indeed, we
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Figure 6. Involvement of UFD2, RAD23, DSK2, and RPN10 in SPT23 Degradation and ERAD
(A) ufd2, rpn10, and rad23 dsk2 show hypersensitivity toward oleic acid. The respective single and double mutant strains were plated
in 5-fold serial dilutions on full media (YPD) supplemented with increasing amounts of oleic acid and incubated at 30C for 2 days.
(B) The upper panels show expression shutoff experiments done at 30C with wt, ufd2, rpn10, rad23 single mutants, and ufd2 rpn10 and
rad23 dsk2 double mutants expressing mycSPT23 from the GAL1-10 promoter. Samples were taken after promoter shutoff at the time points
indicated and analyzed by an anti-myc immunoblot. Note that SPT23 p90 is generated by processing from its p120 precursor and that the processed
molecule p90 is short-lived in wt (Hoppe et al., 2000). Therefore, degradation starts with a delay, and we measured the p90 decay from the 20 min
time point (asterisk). The stable ER membrane protein DPM1 was used as control. The graph shows the quantification of mycp90 decay. The three
lower panels show similar shutoff experiments with wt and temperature-sensitive rsp5-1 and cim3-1 cells grown at 37C.
(C) Expression shutoff experiments similiar to (B) with cells expressing the ERAD substrates mycHMG2 (upper row) and DEG1-FLAGSEC62 (lower
row). Samples were analyzed by anti-myc and anti-FLAG immunoblots. The graphs show the quantification of the respective protein levels
(time point zero was set as 100%).
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Figure 7. Model for a CDC48/UFD2-Depen-
dent Escort Pathway
A protein substrate (brown; possibly bound
to a partner protein) is modified by one or
two ubiquitin moieties (red) using E1, E2, and
E3 enzymes. The oligoubiquitylated substrate
is then recognized by the CDC48UFD1/NPL4 com-
plex (dark gray) and liberated from its poten-
tial partner protein. CDC48 recruits E4 (UFD2;
green), which extends the ubiquitin chain by
a few extra ubiquitin moieties (size-restricted chains). Subsequently, UFD2 recruits RAD23 (or DSK2; blue), which binds the ubiquitin-protein
conjugate and delivers it to the proteasome for degradation. See text for details.
strate that, in addition to the CDC48UFD1/NPL4 chaperone, Multiubiquitin Chain Size Restriction
Unexpected was the observation that the multiubiquitinthe downstream-acting factorsUFD2, RAD23, andDSK2
chains catalyzed by E4 in the presence of CDC48 werealso contribute to ERAD pathways. Moreover, our find-
relatively short, harboring as few as three to six ubiquitinings also indicate that UFD2- and RPN10-dependent
moieties. The significance of this finding became appar-pathways are partially redundant.
ent when we realized that these chains nevertheless
contain sufficient ubiquitin moieties that are adequate,
if not optimal (Raasi et al., 2004), for being recognizedDiscussion
byRAD23 andDSK2.Most importantly, without E4 activ-
ity, the chains are too short (one to two ubiquitin moie-An Escort Pathway to the Proteasome
ties) for RAD23/DSK2 binding. Thus, E4 is a crucialIn this work, we describe a pathway in which ubiquitin
switch, which triggers degradation by adding just oneconjugates are escorted to the proteasome by a succes-
to two ubiquitin moieties to the conjugate. RAD23 andsion of interacting factors. Strikingly, all escort factors
DSK2 act at the end of the cascade as they bind both E4involved are ubiquitin binding proteins. In our model of
(UFD2) and proteasomes. In contrast, the proteasomalthis pathway (Figure 7), oligoubiquitylated substrates
ubiquitin receptor RPN10 does not bind UFD2 and hasare first recognized by the substrate-recruiting cofac-
no significant affinity for size-restricted chains. Eventors of CDC48, relocated onto the bound E4 enzyme for
so, RPN10 contributes to p90 degradation and ERAD,multiubiquitylation, and subsequently handed over to
suggesting that a few substrates can escape size re-RAD23/DSK2 for proteasomal targeting and degrada-
striction (or aremultiubiquitylated without a requirementtion. Central to this pathway is CDC48, which is posi-
for UFD2) and are targeted to proteasomes via an alter-tioned strategically as it connects substrate recruitment
native RPN10-dependent route.with multiubiquitylation and proteasomal targeting. This
How the CDC48 complex might accomplish size re-ring-shaped enzyme is thought to undergo ATP-depen-
striction of multiubiquitin chains is currently unclear. Andent movements by which the enzyme can take protein
intriguing possibility is that the putative six ubiquitincomplexes apart (Rouiller et al., 2002). CDC48 may thus
binding sites on the hexameric CDC48 enzyme mightfunction similar to the relatedAAA-ATPaseNSF (SEC18),
help to coordinate and limit chain formation. On thewhich disassembles SNARE bundles (Brunger and De-
other hand, size restriction could be a common activityLaBarre, 2003). The handiness of having such an activity
of several ubiquitin binding proteins. RAD23 was re-early in a proteolytic pathway becomes particularly evi-
ported to inhibit multiubiquitylation in vitro, and it hasdent for the OLE and ERAD pathways. In the OLE path-
been suggested that it thereby prevents degradation
way, this activity is employed to segregate the pro-
(Ortolan et al., 2000). However, RAD23 can still bind the
cessed, monoubiquitylated SPT23 transcription factor
generated short chains, and thus we rather argue that it
from its uncleaved partner molecule at the ER mem- does not function as an inhibitor but that it may possess
brane. For ERAD, the CDC48 machinery is thought to ubiquitin chain size-restriction activity as well. A re-
mobilize ubiquitylated ERAD substrates from the ER duced number of ubiquitin moieties in a chain to a size
channel. Generalizing from these two cases, we postu- that is still sufficient for proteasomal targeting would
late that CDC48 might be able to selectively remove a not only be economical but would also ease ubiquitin
particular protein from a protein complex. If coupled to chain disassembly. Moreover, we propose that size re-
a proteasomal pathway, this activity would permit the striction might also prevent undesired side reactions of
selective elimination of a single subunit of an oligomeric ubiquitin chain formation, such as tree-like, branched
protein complex. modifications that arise if more than one lysine residue
It is interesting to note that theOLEandUFDpathways of a ubiquitin moiety is used for chain formation. In fact,
share many components. Furthermore, similar to SPT23 onemight even entertain the dissenting idea that heavily
p90, also the UFD substrate Ubi-Progal is predomi- ubiquitylated substrates that accumulate to detectable
nantly a nuclear protein, and its nuclear localization de- levels in vivo are precisely those that are less compatible
pends on the activity of the CDC48UFD1/NPL4 complex (Sup- with proteasomal degradation.
plemental Figure S4). Thus, we propose that the original
UFD screen (Johnson et al., 1995) primarily identified a The Significance of E4 Enzymes
pathway that acts on mono/oligoubiquitylated sub- Multiubiquitin chain assembly is often a processive re-
action that does not depend on E4 enzymes. This mech-strates.
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al., 1999). The ufd2U-box strain and the rad 23 and dsk2 deletionanism may advance rapid degradation but allows only
mutants were generated by chromosomal replacement with TRPmodest possibilities for regulation. In contrast, a two-
and kanMX cassettes, respectively (Knop et al., 1999). The doublestep reaction, i.e., oligoubiquitylation followed by E4-
mutants ufd2 rad23, ufd2 dsk2, and rad23 dsk2 were ob-
catalyzed multiubiquitylation, could offer another layer tained by crossing. Strains npl4-1, cdc48-6, rsp5-1, and cim3-1
of control and gives the possibility for two consecutive were gifts by P. Silver, K.-U. Fro¨hlich, J. Huibregtse, and C. Mann,
respectively. When indicated, genes were chromosomally taggedfunctions. The significance of E4 is particularly compre-
with a triple-myc tag (Knop et al., 1999). Plasmids expressing Ub-hensible for SPT23. This transcription factor is activated
Progal (Bachmair et al., 1986), ubiquitin and mycubiquitin (Ellisonin the cytosol by monoubiquitylation and proteasomal
and Hochstrasser, 1991), and mycHMG2 and DSK2-GST were giftsprocessing and is inactivated by E4-mediated multiubi-
of A. Varshavsky, M. Hochstrasser and R. Hampton, and M. Rose,
quitylation and degradation. respectively. The protein Deg1SEC62 is analogous to the Deg1SEC62FLAG
Albeit its involvement in ERAD, the bulk of UFD2 ap- construct described previously (Mayer et al., 1998), except that it
has a FLAG tag N-terminal of SEC62 (Deg1-FLAGSEC62). Constructspears to reside in the nucleus. Notably, we found that
expressing tagged versions of SPT23, CDC48, and UFD2 were de-the nuclear localization of UFD2 is influenced by CDC48
scribed previously (Hoppe et al., 2000; Koegl et al., 1999; Rape etand UFD1 (Supplemental Figure S3). An interpretation
al., 2001). Two-hybrid interactions were done with pGAD-CDC48of this finding is that a pool of UFD2 is imported into
and pGBT9-UFD2 as described (Braun et al., 2002; Koegl et al.,
the nucleus piggybackwith CDC48 (andUFD1), possibly 1999), and the RAD23 open reading frame and UFD2 C-terminal
together with bound ubiquitylated substrates. This sce- deletion constructs were cloned by PCR into pGAD424 and
pGBT9, respectively.nario is particularly attractive for the transcription factor
SPT23 p90 because, if ubiquitylated p90 would enter
the nucleus in association with CDC48, it might even be Expression Plasmids and Protein Purification
Bacterial expression of GST fusions of UFD2-U-box, UFD2U-box,protected against premature degradation. A regulated
UFD1, RPN10, RAD23, CDC48, CDC481–208aa, CDC48208–835aa, andtransfer of monoubiquitylated p90 onto E4 would then
DSK2 were done from pGEX (Amersham) vectors; His-taggedset off multiubiquitylation and degradation. It is worth
CDC48 from pQE (Qiagen); Ubi-GST, Ubi-ProtA, HisUFD2, and HisNPL4
mentioning that our results might be directly linked to from pET (Novagen); and maltose binding protein (MBP)-UFD2 from
the finding that certain transcription factors gain trans- pVL1393 (Pharmingen) vectors. Details of constructs are available
activation activity by mono/oligoubiquitylation (Mura- upon request. The GSTUFD1/HisNPL4 complex was coexpressed in
E. coli and purified in two sequential chromatography steps usingtani and Tansey, 2003) and that transactivation and tran-
the His and GST tags. For some studies (Figures 2D, 2E, 3B, andscription factor degradation is often coupled. Thus, it
5A), the GST tag was cleaved off by thrombin (Novagen). Ubi-Progalis conceivable that ubiquitylation of SPT23 plays four
was purified by a p-aminobenzyl-1-thio--galactopyranoside aga-
consecutive roles: SPT23 processing, p90 mobilization, rose column (Sigma-Aldrich). MBP-UFD2 was purified from extracts
p90-mediated transcription, and, after E4-catalyzed of bacculovirus-infected SF9 cells by an amylose resin (New En-
multiubiquitylation, p90 degradation. gland Biolabs).
Ubiquitylation ReactionsRedundancy and Directionality
Ubiquitylation reactions were done essentially as described (KoeglOur data revealed that different proteolytic substrates
et al., 1999) using Ubi-GST, Ubi-ProtA, and Ubi-Progal as sub-use distinct routes for proteasomal targeting. Particu-
strates. The UBA1, UBC4, and UFD4 enzymes used are crude ex-larly striking examples are ERAD substrates, which all
tracts of bacculovirus-infected insect cells, which strongly overex-
seem to depend on CDC48UFD1/NPL4 for mobilization from press the respective recombinant proteins (Koegl et al., 1999).
the ER but use in subsequent steps different, occasion- Bacterially expressed His-tagged UFD2 was used as a purified pro-
tein. The in vitro ubiquitylation of a cyclin B N-terminal fragmentally even parallel pathways. More generally, we propose
(NT) was performed essentially as described (Kramer et al., 1998)that most proteolytic substrates are escorted to the pro-
with yeast E1 (Boston Biochem Inc.), the E2 enzyme UbcX (ex-teasome by ubiquitin binding proteins. In some cases,
pressed and purified from E. coli), and APC/C isolated from aas shown here, proteasomal targeting is organized by
“high90 extract” (Stemmann et al., 2001) by immunoprecipitation
a succession of escorting factors. One role of these with monoclonal anti-CDC27 antibody (Sigma-Aldrich) immobilized
proteins is probably to shield the conjugates against the on protein G magnetic beads (Dynal).
activity of ubiquitin hydrolases (Pickart, 2001). Another
function is suggested by our finding that the distinct Binding Assays
escort factors have different binding properties with re- For binding assays (Figures 4 and 5), equimolar amounts of GST
fusions were bound to glutathione beads for 60 min at 4C. Afterspect to the multiubiquitin chain length. UFD2 can rec-
washing, the beadswere incubatedwith purified proteins or extractsognize monoubiquitylated substrates readily. RAD23
as indicated for 60 min at 4C, extensively washed, and boiled inandDSK2 apparently need three ormore ubiquitinmoie-
SDS sample buffer. All steps were performed in PBS with 0.1%
ties for binding, whereas RPN10 needs even longer Triton X-100.
multiubiquitin chains. Thus, a crude counting mecha-
nism, a loose “ubiquitin number code,” may provide
Immunotechniques
directionality anddictate thepathwayused for proteaso- For immunoprecipitations, cells were grown to an OD600 of 0.5 at
mal targeting. 30C (ts mutants were shifted to 37C for another 3 hr) and lysed
by glass bead disruption. Cleared lysates were subjected to immu-
noprecipitation with antibodies as indicated in lysis buffer supple-Experimental Procedures
mented with 0.1% Triton X-100. After 90 min, protein G agarose
beads were added for another 60 min at 4C. The immunoprecipita-Cloning and Yeast Techniques
Media and plateswere supplementedwith 0.2%oleic acid dissolved tion against ubiquitin was done with crude extract in the presence
of 0.05% Tween 20. Bound protein was eluted with 1% SDS at 65C.in Nonidet P40 (0.2% final) when indicated. The ufd1-2, ufd2,
rpn10, andufd2rpn10mutants have been described previously, Antibodies were purchased from Santa Cruz (polyclonal anti-myc),
Promega (monoclonal anti--galactosidase) and Roche (mono-and all strains are derivatives of DF5 (Hoppe et al., 2000; Koegl et
An Escort Pathway to the Proteasome
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clonal anti-VSV). Anti-CDC48 andUFD2 antibodieswere affinity puri- of the 26S proteasome subunits from plants. Mol. Biol. Rep. 26,
137–146.fied. The RAD23 antiserum was a gift of S.A. Johnston.
Ghislain, M., Dohmen, R.J., Levy, F., and Varshavsky, A. (1996).
Expression Shutoff Experiments Cdc48p interacts with Ufd3p, a WD repeat protein required for ubi-
Pulse-chase and promoter shutoff experiments were done essen- quitin-mediated proteolysis in Saccharomyces cerevisiae. EMBO J.
tially as described (Braun et al., 2002; Mayer et al., 1998) with strains 15, 4884–4899.
expressing mycSPT23HA and the Deg1-FLAGSEC62 variant under the con- Hitchcock, A.L., Krebber, H., Frietze, S., Lin, A., Latterich, M., and
trol of the GAL1-10 promoter and with strains expressing mycHMG2 Silver, P.A. (2001). The conserved npl4 protein complex mediates
under the control of the ADH1 promoter. Quantification of chemilu- proteasome-dependent membrane-bound transcription factor acti-
minescence signals was performed by using a CCD camera (LAS vation. Mol. Biol. Cell 12, 3226–3241.
1000, Fujifilm) as described (Braun et al., 2002). In case of HMG2,
Hoppe, T., Matuschewski, K., Rape, M., Schlenker, S., Ulrich, H.D.,the high molecular weight smear representing ubiquitylated species
and Jentsch, S. (2000). Activation of a membrane-bound transcrip-was also taken into account to determine the decay rate.
tion factor by regulated ubiquitin/proteasome-dependent pro-
cessing. Cell 102, 577–586.Acknowledgments
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